Progetti FP7 coordinati da "Universitair medisch centrum utrecht"

# progetto  anno  totale costo  contributi 
1 COPACETIC "COPD Pathology: Addressing Critical gaps, Early Treatment and Innovative Concepts" 2008 4˙020˙859.00 2˙981˙143.00
2 HANDOVER Improving the Continuity of patient care Through Identification and implementation of Novel patient handoff processes in Europe 2008 3˙443˙100.00 2˙623˙200.00
3 MDDANEURODEV Molecular coding and subset specification of dopamine neurons generating the the meso-limbic and nigro-striatal system 2009 3˙420˙935.00 2˙582˙749.00
4 CONCORD CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions 2009 3˙937˙759.00 2˙994˙192.00
5 KINSIGN Guarding Genome Stability: Dynamic Control of Chromosome Segregation by Kinetochore Signalling Pathways 2009 1˙572˙000.00 1˙572˙000.00
6 MECHWNTSIGNALS Mechanisms of Wnt Signaling Initiation 2009 1˙513˙800.00 1˙513˙800.00
7 OPTIMISE OPtimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) 2010 14˙900˙190.00 11˙187˙685.00
8 SABDII Staphylococcus aureus biofilm dynamics and innate immunity 2010 45˙000.00 45˙000.00
9 MINDS Microvesicle-inspired drug delivery systems 2010 1˙338˙000.00 1˙338˙000.00
10 EURO-MOTOR European multidisciplinary ALS network identification to cure motor neuron degeneration 2011 11˙939˙816.00 8˙994˙361.00
11 PHARMACHILD Long-term PHARMacovigilance for Adverse effects in Childhood arthritis focussing on Immune modulatory drugs 2011 3˙924˙102.00 2˙973˙976.00
12 RETEBESKO Rechargeable Telemetry-Based Electrochemical Sensors: Kidney Oxygenation and health 2011 238˙119.00 238˙119.00
13 PRINTCART Bioprinting of novel hydrogel structures for cartilage tissue engineering 2011 265˙944.00 265˙944.00
14 VIRUSSHCREEN Discovery of novel aspects of host-pathogen interactions through the use of powerful genome-wide shRNA libraries 2011 100˙000.00 100˙000.00
15 EVOTAR Evolution and Transfer of Antibiotic Resistance 2011 16˙044˙083.00 11˙997˙391.00
16 R-GNOSIS Resistance in Gram-Negative Organisms: Studying Intervention Strategies 2011 15˙654˙161.00 11˙999˙999.00
17 SOUND PHARMA Image Guided Local Drug Delivery from Nanocarriers using Focused Ultrasound 2011 2˙500˙000.00 2˙500˙000.00
18 EUTRAIN EUropean TRanslational training for Autoimmunity & Immune manipulation Network 2012 3˙762˙774.00 3˙762˙774.00
19 SURFACE Gram positive Surface proteins in immune evasion 2012 169˙535.00 169˙535.00
20 MECHFXR "Towards FXR-mediated therapeutic intervention: Understanding how FXR integrates metabolic, endocrine and inflammatory signaling." 2012 183˙805.00 183˙805.00
21 TARGETMV TARGET MV: Proof of concept study to commercialise a microvesicle-based drug delivery system 2012 158˙600.00 145˙210.00
22 CIRCUMVENT Closing in on Runx3 and CXCL4 to open novel avenues for therapeutic intervention in systemic sclerosis 2012 1˙500˙000.00 1˙500˙000.00
23 TOP TOwards Personalized medicine: defining the role of the bone marrow microenvironment in multiple myeloma 2012 274˙889.00 274˙889.00
24 STEM-TECH STEM-TECH: Introducing proprietary stem cell marker technology for the life sciences market 2013 163˙100.00 148˙280.00
25 WNTSAPP WNT-mediated signal relay in stem cells and oncogenesis - from basic biology to applications 2013 4˙000˙164.00 4˙000˙164.00
26 ICONNECT Intracranial COnnection with Neural Networks for Enabling Communication in Total paralysis 2013 2˙498˙829.00 2˙498˙829.00
27 AUTOIMMUNITY RASGRP1 Functional analysis of RasGRP1 SNPs in autoimmune disease 2013 259˙745.00 259˙745.00
28 SWITCHR5-X4 Determinants of the switch from R5- to X4-tropic virus in HIV-1 infected individuals 2013 183˙469.00 183˙469.00
29 ASTERIX Advances in Small Trials dEsign for Regulatory Innovation and eXcellence 2013 4˙141˙786.00 2˙999˙881.00
30 SMALLVESSELMRI Towards understanding cerebral small vessel disease: Innovative, MRI-based, functional markers to discover the terra incognita between large vessels and macroscopic brain lesions 2013 1˙499˙560.00 1˙499˙560.00
31 CARPEDIEM Cardio Renal Paradigms ElucidateD through an International Exchange ScheMe 2014 134˙400.00 134˙400.00
32 FXR-IBD Industry-Academia exchange to further FXR-based therapeutic intervention and non-invasive diagnosis in Inflammatory Bowel Disease 2014 1˙486˙100.00 1˙486˙100.00
33 EXCELSIOR The Expression of CXC chemokine ligand 4 in Systemic Sclerosis and its Role in the regulation of immune and fibrotic responses 2014 183˙469.00 183˙469.00
34 MICROSCAP MicroRNA targeting to achieve Systemic Sclerosis Control and Prediction 2014 175˙974.00 175˙974.00

Altri progetti

L'Ente universitair medisch centrum utrecht partecipato anche in questi progetti.